AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 17 November 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00736-08v1
53/1/333    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Monteiro, J.
Right arrow Articles by Gales, A. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monteiro, J.
Right arrow Articles by Gales, A. C.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.00736-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

First Report of KPC-2-producing-Klebsiella pneumoniae in Brazil

Jussimara Monteiro*, Anderson Fernandes Santos, Marise Dutra Asensi, Gisele Peirano, and Ana Cristina Gales

Laboratório LEMC/ALERTA, Disciplina de Infectologia, Universidade Federal de São Paulo, São Paulo, Brazil; Laboratório de Enterobactérias, Departamento de Bacteriologia, Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil

* To whom correspondence should be addressed. Email: jussimara.monteiro{at}lemc.com.br.


  Abstract

The carbapenems are regarded as the preferential therapeutic option for treatment of serious multidrug-resistant Gram-negative health-care associated infections. ...






Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.